4
Changes in Ownership
ImmunityBio, Inc. Filed Acc 0001326110-22-000018
Options or other derivatives
- CEO & President acquired 700,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Adcock Richard · CEO & President
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-23 | Grant or award : show line 1 in the form Stock Option (right to buy) | +350,000 | 350,000 | D |
| 2022-03-23 | Grant or award : show line 2 in the form Stock Option (right to buy) | +350,000 | 350,000 | D |
Loading xslF345X03/wf-form4_164825664654486.xml…